Introduction: Approximately 30% of the population is colonized with Staphylococcus aureus on the skin, mucous membranes, and in the anterior part of the nose. Two types of carriers have been described in addition to non-carriers: intermittent carriers and persistent carriers. In persistent carriers, the same strain of S. aureus can and often does persist for months or even years, indicating that the species has developed special mechanisms to persist in this environment, in addition to being a multifactorial process involving genetic aspects of the host, virulence factors of the pathogen and the possible interactions between the microbiota, the host and S. aureus.
The objective of this work was to investigate changes in the pattern of resistance to antibiotics in persistent and intermittent S. aureus strains.
Methods: Pharyngeal and nasal exudates were collected from 98 university students once a month for three months. The exudates were incubated in Trypticaseine Soy Broth at 37 °C for 24 h, followed by seeding in Salt and Mannitol Agar Petri dishes using the cross-streak method and re-seeding to obtain isolated colonies. All strains that were coagulase-positive mannitol fermenters were identified as S. aureus. If a person presented three isolates of S. aureus, they were considered persistent carriers; if they presented one or two isolates in a row, they were considered intermittent carriers; and if the bacteria were never isolated, they were considered non-carriers. All strains of S. aureus underwent an antibiogram against ciprofloxacin, fosfomycin, trimethoprim–sulfamethoxazole, penicillin, vancomycin, tetracycline, erythromycin, oxacillin, clindamycin, gentamicin and cephalothin using the Kirby–Bauer method and the minimum inhibitory concentration for oxacillin, following the indications of the CLSI.
Results: We analyzed 61 women (62.2%) and 37 men (37.7%) with a mean age of 21.1 (±5.7) years, of which 18 were persistent carriers in both anatomical sites (18.3%), 19 were persistent carriers exclusively in the pharynx (19.3%), and no persistent carriers exclusive to the nose were found. A total of 27 were intermittent carriers in the nose (28.5%) and 34 were intermittent carriers in the pharynx (34.7%). For persistent strains, an 80% resistance was found for penicillin, 14% for fosfomycin, 14% for trimethoprim–sulfamethoxazole, 12% for clindamycin, 7 % for erythromycin, 4% for tetracycline, and 2.7% for vancomycin. The other antibiotics (ciprofloxacin, oxacillin, gentamicin and cephalothin, less than 1% of resistant strains were found). Regarding the intermittent strains, it was found that 74% are resistant to penicillin, 14% are resistant to erythromycin, 17% are resistant to clindamycin, 10% are resistant to oxacillin and trimethoprim–sulfamethoxazole, 8.6% are resistant to tetracycline, and 6% are resistant to fosfomycin. The antibiotics ciprofloxacin, vancomycin, gentamicin and cephalothin presented resistance in less than 1% of S. aureus strains.
Discussion: The average resistance to antibiotics of the persistent and intermittent S. aureus strains was very similar; however, the variation in resistance between doses presented more variation between the intermittent strains, particularly in trimethoprim–sulfamethoxazole and oxacillin antibiotics.
Conclusions: More persistent carriers of S. aureus were found in the pharynx and nose than intermittent carriers in one or both sites. The variation in the percentage of resistance to an antibiotic was found to be more important in the intermittent strains than in the persistent ones.
Supplementary Materials
The following are available online at https://www.mdpi.com/article/10.3390/eca2022-12719/s1.
Author Contributions
Conceptualization, S.G.-G., A.H.-P. and J.B.-M.; methodology, S.G.-G., A.H.-P. and J.P.R.; formal analysis, S.G.-G., A.H.-P. and J.P.R.; writing—original draft preparation, S.G.-G., A.H.-P. and J.B.-M., writing—review and editing S.G.-G., A.H.-P., J.P.R. and J.B.-M. All authors have read and agreed to the published version of the manuscript.
Funding
This work was support by Special Research Support Program of UAM.
Institutional Review Board Statement
The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee and the Research Committee of the Division of Biological and Health Sciences of the Universidad Autónoma Metropolitana-Xochimilco within the project: “Molecular characterization of Staphylococcus aureus strains isolated in healthy carriers of the Mexican community”, in the 1/18 session held on 8 February 2018. The identification code is DCBS.CD.056.18.
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
Not applicable.
Conflicts of Interest
The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).